| Clinical data | |
|---|---|
| Trade names | Androxan, Neo-Ponden, Neo-Pondus |
| Other names | 17α-Methyl-5α-androstano[3,2-c]isoxazol-17β-ol |
| Routes of administration | By mouth |
| Drug class | Androgen;Anabolic steroid |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C21H31NO2 |
| Molar mass | 329.484 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Androisoxazole (brand namesAndroxan,Neo-Ponden,Neo-Pondus), also known as17α-methyl-5α-androstano[3,2-c]isoxazol-17β-ol, is anorally activeanabolic-androgenic steroid (AAS) and a17α-alkylatedderivative ofdihydrotestosterone (DHT) that is marketed inSpain andItaly.[1][2][3][4] It is closely related tostanozolol, differing only in having anisoxazole instead ofpyrazolering fused to the A ring,[4] and is also related tofurazabol,prostanozol, anddanazol.
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byadding missing information. |